Through its bystander effect, T-DXd can deliver its cytotoxic payload to neighboring tumor cells that are heterogeneously expressing HER2 in addition to targeting HER2-expressing tumor cells with high levels of HER2 [13, 14]. Here, ERBB2 is linked to neoplasm.